Cargando…

Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?

We bring to you our viewpoint and a snapshot of the journey of convalescent plasma therapy (CPT) in the management of ongoing coronavirus disease 2019 (COVID-19) pandemic. We also discuss how best to use the updated data on this important treatment option and maximize benefit for our patients, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Parikh, Purvish M., Sood, T., Agarwala, V., Kate, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Private Ltd 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380149/
https://www.ncbi.nlm.nih.gov/pubmed/34430518
http://dx.doi.org/10.1055/s-0041-1733351
_version_ 1783741140532461568
author Parikh, Purvish M.
Sood, T.
Agarwala, V.
Kate, S.
author_facet Parikh, Purvish M.
Sood, T.
Agarwala, V.
Kate, S.
author_sort Parikh, Purvish M.
collection PubMed
description We bring to you our viewpoint and a snapshot of the journey of convalescent plasma therapy (CPT) in the management of ongoing coronavirus disease 2019 (COVID-19) pandemic. We also discuss how best to use the updated data on this important treatment option and maximize benefit for our patients, thereby saving lives, especially in resource constraint settings.
format Online
Article
Text
id pubmed-8380149
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Thieme Medical and Scientific Publishers Private Ltd
record_format MEDLINE/PubMed
spelling pubmed-83801492021-08-23 Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality? Parikh, Purvish M. Sood, T. Agarwala, V. Kate, S. South Asian J Cancer We bring to you our viewpoint and a snapshot of the journey of convalescent plasma therapy (CPT) in the management of ongoing coronavirus disease 2019 (COVID-19) pandemic. We also discuss how best to use the updated data on this important treatment option and maximize benefit for our patients, thereby saving lives, especially in resource constraint settings. Thieme Medical and Scientific Publishers Private Ltd 2021-01 2021-08-21 /pmc/articles/PMC8380149/ /pubmed/34430518 http://dx.doi.org/10.1055/s-0041-1733351 Text en MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Parikh, Purvish M.
Sood, T.
Agarwala, V.
Kate, S.
Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?
title Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?
title_full Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?
title_fullStr Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?
title_full_unstemmed Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?
title_short Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?
title_sort has convalescent plasma therapy hesitancy increased covid-19 mortality?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380149/
https://www.ncbi.nlm.nih.gov/pubmed/34430518
http://dx.doi.org/10.1055/s-0041-1733351
work_keys_str_mv AT parikhpurvishm hasconvalescentplasmatherapyhesitancyincreasedcovid19mortality
AT soodt hasconvalescentplasmatherapyhesitancyincreasedcovid19mortality
AT agarwalav hasconvalescentplasmatherapyhesitancyincreasedcovid19mortality
AT kates hasconvalescentplasmatherapyhesitancyincreasedcovid19mortality